Error

Sorry, there was a problem displaying the requested page.

Biotherapies: Donor to Patient

We use cookies to improve the function of this site and enhance the user experience.
Learn more about our cookie policy and how to modify your cookie settings.
UK/CORP/15-0012l. Date of preparation: July 2015
United Kingdom
Search    
Include All CSL Behring Country Sites

Biotherapies: Donor to Patient

From Plasma Donation to Final Product
Manufacturing plasma therapeutics is a complex, highly sophisticated process that takes about seven months from plasma donation to completion of the finished product. Since plasma is a biological product, rigorous testing and quality assurance occur throughout the manufacturing process. In this way, we are assured of producing high-quality and effective products, with an excellent safety pedigree.

Plasma Therapies from Donor to Patient

Biotherapies: Donor to Patient

UK/CORP/15-0012b Date of preparation: July 2015